Predictors of response to immunomodulation in patients with myasthenia gravis
- 18 November 2011
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 45 (5), 648-652
- https://doi.org/10.1002/mus.23236
Abstract
Introduction: Factors determining response to intravenous immunoglobulin (IVIg) and plasmapheresis in myasthenia gravis (MG) have not been evaluated systematically. Methods: This study included patients treated with IVIg (n = 63) or plasmapheresis (n = 42) from two trials evaluating IVIg vs. placebo or plasmapheresis in MG. Response was defined as improvement in the quantitative myasthenia gravis score (QMGS) of ≥3.5 points at day 14. Baseline clinical, electrophysiological, and immunological factors were analyzed as predictors. Results: Baseline QMGS, acetylcholine receptor antibody (AChRAb) positivity, single‐fiber electromyography (SFEMG) jitter, and percent abnormal pairs and percent blocking pairs were higher in responders than in non‐responders. Using multivariate logistic regression, the odds ratio for response was 13.0 (1.01–381.5) in QMGS 11–17 and 15.3 (1.34–414.3) in QMGS >17 compared with QMGS Conclusions: Baseline QMGS, AChRAb positivity, and SFEMG parameters were more abnormal in patients who responded to treatment. Using multivariate regression, baseline QMGS remained as the only significant independent predictor of response. Muscle Nerve, 2012Keywords
This publication has 31 references indexed in Scilit:
- Comparison of IVIg and PLEX in patients with myasthenia gravisNeurology, 2011
- Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology, 2010
- Surrogate therapeutic outcome measures in patients with myasthenia gravisMuscle & Nerve, 2007
- IV immunoglobulin in patients with myasthenia gravisNeurology, 2007
- A Comparison of Electrodiagnostic Tests in Ocular Myasthenia GravisJournal of Clinical Neuromuscular Disease, 2005
- A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- A Clinical Therapeutic Trial of Cyclosporine in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1993
- Treatment of myasthenia gravis with high-dose intravenous immunoglobulinActa Neurologica Scandinavica, 1991
- RESPONSE TO PLASMAPHERESIS AND IMMUNOSUPPRESSIVE DRUG THERAPY IN SIXTY MY ASTHENIA GRAVIS PATIENTSAnnals of the New York Academy of Sciences, 1981
- Clinical electrophysiology in myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980